CSOP CSI 300 Index Daily (2x) Leveraged Product(07233)

4.352-0.062-1.40%

Market data delayed 15 minutes

    • 小啡熊
      ·
      2025-04-14
      Comment
      Report
      Tiger_Trade Feed
      ·
      2023-09-26

      Lesson 3: Practical Trading Techniques for Hong Kong ETFs

      Hello, Tigers! In the previous lesson, we discussed the three key types of Hong Kong ETFs. In this lesson, we will continue to delve into the practical knowledge of trading Hong Kong ETFs.In this session, we will guide you through hands-on trading examples of Hong Kong ETFs from the following three perspectives:Trading ETFs on the Tiger Trade app.Margin tradingRequirements for margin trading1.Trading ETFs on the Tiger Trade app(1) Take "XL2CSOPCSI 300 (07233.HK)" as an example; open the "Tiger Trade app," click on "Home," then tap the search icon at the top right corner, enter the ETF code "07233," click on "Trade," and then click on "Buy/Long." (Source:Tiger Trade app) (Source:Tiger Trade app)(2) In the trading interface, input the desired "
      Lesson 3: Practical Trading Techniques for Hong Kong ETFs
      TOPPotatotoro: Great ariticle, would you like to share it?
      2
      Report
    • Company Profile

      Company Name
      CSOP CSI 300 Index Daily (2x) Leveraged Product
      Market
      SEHK
      Establishment Date
      - -
      Employees
      - -
      Office Location
      - -
      Website
      - -
      Zip Code
      - -
      Phone
      - -
      Fax
      - -
      Introduction
      The investment objective of the Product is to provide investment results that, before fees and expenses, closely correspond to twice (2x) the Daily performance of the Index. The Product does not seek to achieve its stated investment objective over a period of time greater than one day.
      • 1D
      • 5D
      • Day
      • Week
      • Month

      Loading ...

      High
      4.390
      Open
      4.390
      Volume%
      0.57
      Low
      4.338
      Close
      4.414
      T/O Rate
      0.68%
       
       
       
       

      Most Discussed